March 02, 2015 7:20 PM ET


Company Overview of Nimbus Discovery, LLC

Executive Profile

Mark Murcko Ph.D.

Senior Vice President of Strategy and Member of the Scientific Advisory Board, Schrödinger, LLC
AgeTotal Calculated CompensationThis person is connected to 3 Board Members in 3 different organizations across 5 different industries.

See Board Relationships


Dr. Mark Murcko, Ph.D. serves as Senior Vice President of Strategy at Schrödinger, LLC. Dr. Murcko serves as Advisor at Nimbus Discovery, LLC. He served as the Chief Technology Officer and Vice President of Vertex Pharmaceuticals Incorporated. Dr. Murcko joined Vertex in 1990 as a Founding Scientist and served as its Senior Research Fellow. He co-invented Agenerase™ (amprenavir) and Lexiva™ (fosamprenavir), Vertex's first two marketed drugs, as well as several other ...

Corporate Headquarters

25 First Street
Cambridge, Massachusetts 02141

United States

Phone: 617-588-2655
Fax: 617-231-0652

Board Members Memberships

There is no Board Members Memberships data available.


Fairfield University
Yale University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Nimbus Discovery, LLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at